Table 1.
N=48 | |
---|---|
Age, yrs ± SD | 52.8 ± 19.7 |
Female:Male (%) | 74:26 |
Race (%) | |
White | 77 |
Black | 4 |
Hispanic | 17 |
Asian | 0 |
Other | 2 |
CTD (N) | |
Systemic sclerosis | 20 |
Rheumatoid arthritis | 8 |
Undifferentiated CTD | 7 |
Poly-/dermatomyositis | 7 |
Systemic lupus erythematosus | 3 |
Primary Sjögren’s syndrome | 3 |
FVC% | 72.1±21 |
FEV1% | 73.7±21 |
DLCO% | 51.6±21 |
MDHAQ components | |
FN | 2.3±1.8 |
PS | 2.7±2.2 |
Pain | 4.2±3.2 |
Fatigue | 4.8±3.2 |
Global | 4.7±2.3 |
RAPID | 11.2±6.6 |
Stiff in AM | 32.5±38.8 |
Joints | 9.8±9.2 |
Dyspnea questionairres | |
D12 | 12.3±10.2 |
UCSD | 45.7±26.6 |
CTD = connective tissue disease; FVC% = percent of predicted normal value for forced vital capacity; FEV1% = percent of predicted normal value for forced expiratory volume at one second; DLCO% = percent of predicted normal value for diffusing capacity for carbon monoxide; MDHAQ = Multi-dimensional Health Assessment Questionairre; FN = physical function; PS = psychological well-being component; RAPID = scale composed of FN, Pain, and patient-assessed global components; D12 = Dyspnea 12; UCSD = University of San Diego Shortness of Breath Questionairre